Enzon Pharmaceuticals Unternehmenskultur

Ms. Jennifer Isacoff McNealey has been Vice President of Investor Relations and Strategy at Calithera Biosciences, Inc. since December 2016. From February 2015 to December 2016, Ms. McNealey served as Senior Director Investor Relations at Calithera Biosciences, Inc. Prior to joining Calithera Biosciences, Inc., Ms. McNealey served as an Advisor to biotechnology companies. In 2005, Ms. McNealey founded Laurient LLC, a research company focused on the biotechnology and pharmaceutical industries, where she worked until 2012. Prior to founding Laurient LLC, Ms. McNealey served as a portfolio manager and biotechnology analyst at various firms, including Paramount Capital, Franklin Templeton, Amerindo Investment Advisors and Morgan Stanley Dean Witter Advisors. She has been a Director of Enzon Pharmaceuticals Inc. since September 25, 2013. Ms. McNealey holds B.A from cornell university and M.H.A from cornell university.